Pre‐donation water and salty snacks to prevent vasovagal reactions among blood donors

• Published in: Transfusion (Philadelphia, Pa.) Pa.), 2023-01, Vol.63 (1), p.156-162
• Main Authors: Lewin, Antoine, Deschênes, Jessyka, Rabusseau, Isabelle, Thibeault, Catherine, Renaud, Christian, Germain, Marc
• Format: Article
• Language: English
• Subjects: Apheresis; Blood; Blood & organ donations; blood center operations; Blood Donors; donors; Drinking Water; Humans; Risk; Risk Factors; Risk groups; Risk reduction; Snacks; Statistical analysis; Statistical significance; Subgroups; Syncope, Vasovagal - epidemiology; Syncope, Vasovagal - etiology; Syncope, Vasovagal - prevention & control; Trends
• ISSN: 0041-1132; 1537-2995
• DOI: 10.1111/trf.17173

Background Minimizing the risk of vasovagal reactions (VVRs) can prevent donor harms and improve donor return. We report the results of a program to reduce VVR rates. Study Design and Methods The program was implemented on June 11, 2017 and consisted in drinking water and eating a salty snack before donating blood, plasma, or platelets. All donations made during the “pre‐program period” (October 11, 2015–June 10, 2017) and “post‐program period” (June 11, 2017–May 11, 2019) were included. Study outcomes comprised VVRs (any severity) and syncopal VVRs, whether employee‐ or donor‐reported. An interrupted time series (ITS) analysis proxied causality based on the “pre‐program trend,” the “immediate trend” (i.e., immediately before versus after the program), and the “post‐program trend”. The relative risk (RR) of VVR (along with confidence intervals [CIs]) was reported, overall and stratified by subgroups based on age, sex, donor type (i.e., first‐time versus repeat), and donation type (i.e., whole blood versus apheresis). Results The monthly VVR rate (any severity) dropped from 4.6% in the pre‐program period to 4.3% in the post‐program period, and never reached its pre‐program level. The ITS analysis revealed a statistically significant and increasing pre‐program trend (RR [95% CI] = 1.011 [1.002–1.020]), a statistically significant and decreasing immediate trend (RR [95% CI] = 0.848 [0.743–0.969]), and a non‐statistically‐significant and stable post‐program trend (RR [95% CI] = 0.999 [0.993–1.006]). Similar trends were observed for nearly all high‐ and low‐risk subgroups. No statistically significant trend was observed for syncopal VVRs. Discussion These results suggest that the herein‐described program durably reduced the incidence of VVRs (any severity) by ~15%.